The protein has a predicted molecular mass of 14.6 kDa after removal of the signal peptide. The apparent molecular mass of Human-BTLA-His is approximately 25-35 kDa due to glycosylation.
Conjugate
Unconjugated
Purity
> 95% by SDS-PAGE and Coomassie blue staining.
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Recombinant Human CD272/BTLA Protein (6xHis Tag) (A318214)
ELISA plates were pre-coated with Recombinant Human CD272/BTLA Protein (6×His Tag) (A318214) at 1 µg/ml (100 µl/well) which can bind Icatolimab Biosimilar - Anti-CD272/BTLA Antibody - BSA and Azide free (A318903) in a linear range of 16-80 ng/ml.
Flow Cytometry - Recombinant Human CD272/BTLA Protein (6xHis Tag) (A318214)
Flow cytometry analysis of 15µg/ml of Recombinant Human CD272/BTLA Protein (6×His Tag) (A318214) on Expi293 cells transfected with human HVEM (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
Publishing research using Recombinant Human CD272/BTLA Protein (6xHis Tag) (A318214)? Please let us know so that we can list the citation on this page.
